Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis
Isocitrate dehydrogenase (IDH)-mutant astrocytomas with homozygous deletion of cyclin-dependent kinase 2A/B (CDKN2A/B-HomoD) are categorized to grade 4 in the new World Health Organization (WHO) classification. However, the clinical implications of CDKN2A/B-HomoD in oligodendrogliomas remain unclear...
Saved in:
Main Authors: | Satoshi NAKASU, Shoichi DEGUCHI, Yoko NAKASU |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Neurosurgical Society
2024-12-01
|
Series: | Neurologia Medico-Chirurgica |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/nmc/64/12/64_2024-0105/_pdf/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma
by: Alexander S. Himstead, et al.
Published: (2025-01-01) -
Prognostic impact of tumor size on cancer-specific survival for postoperative WHO grade II oligodendroglioma: a SEER-based study
by: Qin Lu, et al.
Published: (2025-02-01) -
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
by: Liang Ma, et al.
Published: (2025-01-01) -
Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma
by: Hongbing Cheng, et al.
Published: (2025-01-01) -
Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration
by: Fuda Xie, et al.
Published: (2025-01-01)